Dudediligence.

Hyperfine, Inc

HYPRNASDAQ · Electromedical & Electrotherapeutic Apparatus
Write an idea

Financing

SEC filings to 2026-10-05 · every row opens its filing

No share count on file in the XBRL facts for this window.

Newest

None

No S-3 or F-3 shelf on file in the last 30 months.

$50.0M

B. Riley Securities, agreement of 2025-12-29. No at-the-market sales statement read from a 10-Q or 10-K. 8-K ↗

Warrants

The 10-Q filed 2026-08-06 is not read yet.

Cash

6.4 quarters

$43.5M on 2026-06-30 ÷ $6.8M a quarter of operating cash used, the average of four quarters. 10-Q ↗

Raised
DateWhatSharesPriceGrossFiling
2025-10-15Public offering14,000,000$1.25$17.5M424B5 ↗
2025-02-11Public offering4,511,278$1.33$6.0M424B5 ↗
2025-02-11Registered direct offering4,511,278not read$6.0M8-K ↗

Also on file: up to $40.0M term loan agreed 2026-03-18 8-K ↗